Genexine Stock Price at 146,000 Won... Down 3.5% from Previous Day

Genexine ranked among the top searched stocks for 13 days in the past month.

As of 10:30 AM on the 27th, Genexine is trading at 146,000 KRW, down 3.5% from the previous day. This represents a 23.73% increase compared to August 12. Genexine is known as a company specializing in the development of biopharmaceuticals.

Today, foreigners are tentatively recorded as net sellers of 58,163 shares. Over the past five days, individual investors have net bought 70,603 shares, while foreigners and institutions have net bought 111,465 shares and net sold 32,472 shares, respectively.

On August 25, Genexine became a market issue with the headline "Lymphoma Treatment Receives US FDA Phase 1b Approval, Leading to Price Increase."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.